F Cell viability assay of resistant SKMEL28 cells treated with PLX4032 (PLX, 2 μM), Erlotinib (Erl, 2.5 μM), MK-2206 (2.5 μM), or their combinations. Relative cell viability compare with DMSO control was analyzed by CCK8 assay after drug treatment for 72 hr. 